Bevacizumab and irinotecan for recurrent oligodendroglial tumors.
Taillibert S, Vincent LA, Granger B, Marie Y, Carpentier C, Guillevin R, Bellanger A, Mokhtari K, Rousseau A, Psimaras D, Dehais C, Sierra del Rio M, Meng Y, Laigle-Donadey F, Hoang-Xuan K, Sanson M, Delattre JY.
Taillibert S, et al. Among authors: vincent la.
Neurology. 2009 May 5;72(18):1601-6. doi: 10.1212/WNL.0b013e3181a413be.
Neurology. 2009.
PMID: 19414728